Insights
Insights From Our Experts
Articles
In-Depth with an Industry Leader: Global Launch Ambitions and Paradigm Shifts
Biotech enterprises, driven by the dual goals of treating a maximum patient population and ensuring a robust return on investment, must strategically navigate the complex landscape of global commercialization. Although the United States remains a crucial…
Empower to Impact: Advocacy Training for Meaningful Change
Posted by
Ryan Clarke, LL.B on July 15, 20247/15/24
Advocacy training is central to empowering advocacy champions, and for EVERSANA’s Advocacy & PR group in Canada, it is at the core of the work that they do. In a recent conversation, Ryan Clarke, LL.B., senior…
EVERSANA Named Global Host and Presenting Sponsor of Frontiers Health 2024, Bringing Innovators Together Across Europe and Beyond to Transform Healthcare
Today EVERSANA, a leading provider of global commercial services to the life sciences industry, is proud to announce that we will be the global host and presenting sponsor for Frontiers Health 2024. The two-day event, which…
Report: Integrated Delivery Network Trends and Engagement Strategies Every Drug Manufacturer Needs to Know
Unlock the full potential of your Integrated Delivery Network (IDN) strategies with EVERSANA’s latest Market Research & Insights Report. Drug manufacturers are engaging with IDNs to address pain points and trends, optimize patient outcomes, and foster…
The Integral Role of Global Indirect Treatment Comparison in Europe’s JCA
Discover the integral role of Global Indirect Treatment Comparison (ITC) Programs in Europe’s Joint Clinical Assessment (JCA) in this insightful piece by EVERSANA. Learn why a global ITC program is not just beneficial but essential for…
Transforming the Future of Pharma Commercialization Through Medical Affairs
The pharmaceutical industry is rapidly evolving, and Medical Affairs is at the forefront of this transformation. As a clinician, it is an exciting time to think about the possibilities and how several emerging factors are…
The New AMCP Dossier Format Version 5.0: Key Implications for Strategic Approach
The Academy of Managed Care Pharmacy (AMCP) Format for Formulary Submissions is the industry standard for communicating clinical and economic information to meet the evidentiary requirements/needs of healthcare decision-makers (HCDMs) in the United States. The latest…
European Parliament’s Revision of the General Pharmaceutical Legislation
The European Parliament has adopted a revision of the general pharmaceutical legislation, repealing and amending previous legislation with a set of compromise amendments. According to the European Commission, it has been called “the largest reform in…
Strategic Launch: Accelerating Innovative Therapies in the Chinese Market
Given the recent business and sociopolitical environments, having the right business model is critical to successfully entering the China pharmaceuticals market. In this webinar, we will share relevant examples regarding how other life science companies responded to…
Market Access and the Inflation Reduction Act
The Inflation Reduction Act of 2022 (IRA) institutes Medicare changes that include the ability to negotiate drug prices, limit price increases and cap out-of-pocket costs for beneficiaries. Understanding the far-reaching implications of these provisions is crucial…